15.16
-0.33 (-2.13%)
-0.33 (-2.13%)
Upgrade to Real-Time
Afterhours (Closed)
Low
14.61
High
28.20
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| UroGen Pharma Ltd | URGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.33 | -2.13% | 15.16 | 00:00:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.48 | 15.20 | 15.9478 | 15.50 | 15.49 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 14.97 | 46.91 | 31.94 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,288 | 237,961 | $ 15.48 | $ 3,683,817 | - | 14.61 - 28.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:30:36 | formt | 100 | $ 15.16 | USD |
Period:
Draw Mode:
UroGen Pharma Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 338.05M | 22.30M | 17.36M | $ 11.80M | $ - | -5.92 | -2.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 97.82k | 2.60% |
UroGen Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical URGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.00 | 16.01 | 15.06 | 15.36 | 91,944 | -0.84 | -5.25% |
| 1 Month | 15.71 | 16.18 | 14.61 | 15.37 | 167,048 | -0.55 | -3.5% |
| 3 Months | 18.62 | 19.1854 | 14.61 | 16.38 | 146,976 | -3.46 | -18.58% |
| 6 Months | 22.06 | 28.20 | 14.61 | 18.82 | 166,472 | -6.90 | -31.28% |
| 1 Year | 22.91 | 28.20 | 14.61 | 19.98 | 164,510 | -7.75 | -33.83% |
| 3 Years | 45.46 | 55.49 | 1.00 | 27.81 | 165,571 | -30.30 | -66.65% |
| 5 Years | 13.28 | 69.5676 | 1.00 | 30.88 | 147,255 | 1.88 | 14.16% |
UroGen Pharma Description
| UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. It has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. The company's lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. |
